Effects of Methods on Dry Mouth After Septoplasty Surgery
Launched by EGE UNIVERSITY · Mar 22, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how different methods can help reduce dry mouth after septoplasty surgery, which is a procedure to correct a deviated septum in the nose. The study will take place at Gönen State Hospital between 2025 and 2026 and will involve 81 patients who are scheduled for this surgery. Participants will be divided into three groups: one group will receive ice water to drink, another group will drink water at room temperature, and the third group will receive standard care without any specific treatment for dry mouth. Researchers will measure the dryness of participants' mouths at various times after surgery to see which method is most effective.
To be eligible for the trial, participants must be between 18 and 89 years old, able to communicate in Turkish, and must agree to take part in the study. They should not have any ongoing medical conditions that affect dry mouth, and they must not be smokers or on medications that could influence mouth dryness. If you choose to participate, you can expect to be monitored closely after your surgery, and the study will help improve understanding of how to better manage dry mouth in patients undergoing septoplasty.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 89
- • Able to communicate in Turkish
- • No obstacle to communication
- • Agreeing to participate in the study
- • Conscious and oriented as a result of the evaluation made with SPMT at 30 minutes after the surgery, with a clear airway, no nausea or vomiting
- • Using silicone nasal tampons
- Exclusion Criteria:
- • Patients with a preoperative oral mucous membrane integrity assessment Oral Assessment Guide (OAG) result of over 16
- • Those taking medication that affects dry mouth
- • Those with a chronic disease that affects dry mouth
- • Those undergoing a second simultaneous surgical procedure
- • Those who develop complications during surgery and/or during recovery from anesthesia
- • Patients who smoke will not be included in the study.
About Ege University
Ege University, a prestigious institution located in Izmir, Turkey, is renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, Ege University leverages its extensive academic resources and expertise in various healthcare fields to facilitate innovative clinical studies. The university is dedicated to enhancing patient care through rigorous research methodologies and collaboration with multidisciplinary teams, ensuring the development of effective therapies and interventions. With a strong focus on ethical standards and regulatory compliance, Ege University aims to contribute significantly to the global medical community by fostering groundbreaking discoveries and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Balıkesir, Gönen, Turkey
Patients applied
Trial Officials
Eda Dolgun, Ass. Prof.
Study Director
Ege University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported